Feelnor
Trimetazidine Dihydrochloride tablet

Presentation
Feelnor tablet: Each film-coated tablet contains Trimetazidine Dihydrochloride INN 20 mg.

Description
Feelnor (Trimetazidine) is a unique antianginal and anti-ischaemic agent that display anti-ischaemic effects without inducing haemodynamic changes and improves the status of the ischaemic myocardium.The drug exerts its antianginal effects through a direct cytoprotective action on the myocardium, thereby avoiding the side-effects of impaired left ventricular function, excessive peripheral vasodilation and other disadvantages associated with the use of comparator antianginal agents

Indications and Uses
Feelnor (Trimetazidine) is indicated for-
* Ischaemic heart disease (angina pectoris, sequelae of infarction)
* Adjuvant symptomatic treatment of vertigo and tinnitus
* Adjuvant treatment of the decline visual acuity and visual field disturbances, presumably of vascular origin

Contraindications
Hypersensitivity to Trimetazidine Dihydrochloride.

Dosage And Administration
One tablet (20 mg) thrice daily after meals. No dosage adjustments are required in patients with impaired renal and hepatic function.

Side Effects
Feelnor (Trimetazidine) is safe and well tolerated. The most commonly encountered side effects are gastric discomfort, nausea, headache and vertigo. However, the side effects are mild and non-specific.

Use in pregnancy & lactation
Pregnancy: Studies in animals have not demonstrated a teratogenic effect. However, in the absence of clinical data and for safety reasons, prescription should be avoided during pregnancy.
Nursing Mothers: There is no information on the secretion of Trimetazidine into breast milk. However, breast feeding should be discontinued if the use of Trimetazidine is considered essential.

Commercial Pack
Feelnor tablet: Each box contains 3 blister strips of 10 tablets.;

Other
Paedriatic Use Safety and efficacy in children have not been established with Trimetazidine.